Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Ethnic disparities in the uptake of pharmacy services

On 27 August 2016, UK prime minister Teresa May announced an audit of public services to reveal racial disparities and to help end the injustices that many people experience. This will be led by a unit in the Cabinet Office and will include coverage of health services. It is hoped that it will illustrate how public services treat people from different backgrounds.

At the RPS Annual Conference, held in Birmingham on 4–5 September 2016, London North West Local Practice Forum reported that we had detected ethnic disparities in the uptake of support available in community pharmacies. The context was a campaign to help patients manage their chronic obstructive pulmonary disease (COPD), and support offered included, among other things, medicines use reviews, inhaler technique training and smoking cessation guidance.

We found that Black and Asian patients were statistically underrepresented among the patients accessing the support, when taking into account the ethnic makeup of the localities involved and the ethnic COPD prevalence rates for the localities.

Because patients were offered support on an opportunistic basis when present in the pharmacy, a variety of factors could have influenced utilisation of the support offered. Language issues, diffidence, lack of wish to engage with the pharmacist or simply not being present in the pharmacy are just some examples.

Whatever the reasons, equality of opportunity (viz the support was available to everyone) did not result in equality of outcome, since fewer Black and Asian patients than predicted accessed the support. We suggest that, given the concern expressed by the UK government, pharmacy should be alert to the possibility that services offered opportunistically may not be reaching all sections of population that it serves.

Stephanie Bancroft

Lead and finance lead

Christine Heading

Deputy lead and academic lead

Amira Guirguis

Research and projects lead

Shreya Shah

Communications lead

Usha Shah

Networking lead

Darush Attar-Zadeh

Faculty champion

London North West Local Practice Forum

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20201706

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.